Tiotropium Bromide Monohydrate

DRUG4 trials

Sponsors

Goethe University Frankfurt, Orion Corporation, Orion Pharma

Conditions

Healthy SubjectsHealthy VolunteersSevere asthma exacerbations in partial and uncontrolled preschool asthma

Phase 1

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

CompletedNCT03400241

Orion Corporation, Orion PharmaHealthy Subjects

Start: 2018-02-19End: 2018-04-18Updated: 2018-06-14

Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®

CompletedNCT04850144

Orion Corporation, Orion PharmaHealthy Volunteers

Start: 2021-04-26End: 2021-10-04Updated: 2021-10-25

Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler

CompletedNCT05246046

Orion Corporation, Orion PharmaHealthy Volunteers

Start: 2022-02-16End: 2022-08-03Updated: 2022-08-18

Phase 3

A prospective multicenter placebo-controlled trial to study the efficacy and safety of Tiotropium in preventing severe asthma exacerbations in partial and uncontrolled preschool asthma.

CompletedCTIS2024-513916-84-00

Goethe University FrankfurtSevere asthma exacerbations in partial and uncontrolled preschool asthma

Start: 2022-02-18End: 2025-04-02Target: 152Updated: 2024-06-05